A Novel Dimeric Inhibitor Targeting Beta2GPI in Beta2GPI/Antibody Complexes Implicated in Antiphospholipid Syndrome.
Kolyada, A., Lee, C.J., De Biasio, A., Beglova, N.(2010) PLoS One 5: e15345-e15345
- PubMed: 21179511 
- DOI: https://doi.org/10.1371/journal.pone.0015345
- Primary Citation of Related Structures:  
3OP8 - PubMed Abstract: 
β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. Only the dimeric form of β2GPI generated by anti-β2GPI antibodies is pathologically important, in contrast to monomeric β2GPI which is abundant in plasma.
Organizational Affiliation: 
Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, United States of America.